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[Abstract] Mitochondrial dysfunction is a principal feature of acute pancreatitis (AP) although the 10 
underlying mechanisms are still unclear. AP precipitants induce Ca2+-dependent formation of the 11 
mitochondrial permeability transition pore (MPTP) in pancreatic acinar cells (PACs), leading to ATP 12 
depletion and necrosis. Evaluations of mitochondrial bioenergetics have mainly been performed in 13 
isolated PACs using confocal microscopy, with assessment of mitochondrial membrane potential, 14 
NADH/FAD+ and ATP levels, coupled with patch-clamp electrophysiology. These studies are technically 15 
demanding and time-consuming. Application of Seahorse flux analysis now allows detailed 16 
investigations of bioenergetics changes to be performed in cell populations using a multi-well plate-17 
reader format; rates of oxygen consumption (OCR) and extracellular acidification (ECAR) provide 18 
important information about cellular respiration and glycolysis, respectively. Parameters such as 19 
maximal respiration, ATP-linked capacity and proton leak can be derived from application of a respiratory 20 
function “stress” test that involves pharmacological manipulation of the electron transport chain. The use 21 
of Seahorse Flux analysis therefore provides a quick, and convenient means to measure detailed 22 
cellular bioenergetics and allows results to be coupled with other plate-reader based assays, providing 23 
a fuller understanding of the pathophysiological consequences of mitochondrial bioenergetics 24 
alterations. 25 
Keywords: Mitochondrial dysfunction, Bioenergetics, Seahorse, Respiration, Glycolysis, Pancreatic 26 
acinar cells, Acute pancreatitis  27 
 28 
[Background] Mitochondrial dysfunction is a core feature of acute pancreatitis (AP), a debilitating and 29 
potentially fatal disease for which there is currently no specific therapy (Criddle 2016; Habtezion et al., 30 
2019). The elucidation of pivotal pathological mechanisms which underlie mitochondrial damage in 31 
pancreatic acinar cells (PACs) is paramount for the development of new therapies. Previously evaluation 32 
of mitochondrial bioenergetics in isolated PACs have been mostly performed using confocal microscopy, 33 
including assessments of mitochondrial membrane potential (tetramethyl rhodamine methyl ester: 34 
TMRM), NADH/FAD+ autofluorescence and ATP (Magnesium Green), coupled with patch-clamp 35 
electrophysiology (Voronina et al., 2002; Criddle, et al., 2004; Criddle et al., 2006). Such studies have 36 
pinpointed a reduction of ATP in response to precipitants of AP, via the opening of the mitochondrial 37 
permeability transition pore (MPTP), as a critical event that leads to necrotic cell death (Criddle et al., 38 
2006; Mukherjee et al., 2016); supplementation with intracellular ATP ameliorated damage. Furthermore, 39 
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luciferase measurements in PACs have provided details of changes of both mitochondrial and cytosolic 40 
ATP concentrations induced by pathophysiological stimulation (Voronina et al., 2010). Such 41 
experimental approaches in single cells, however, are technically difficult and time-consuming. In 42 
contrast, population-based assays provide important information about mitochondrial dysfunction and 43 
cell death using a convenient plate-reader format (Armstrong et al., 2019). The use of Seahorse Flux 44 
analysis allows a detailed evaluation of bioenergetics changes to be performed in PACs, measuring 45 
rates of oxygen consumption (OCR) and extracellular acidification (ECAR); these inform about cellular 46 
respiration and glycolysis, respectively. A respiratory function “stress” test can further be applied in which 47 
pharmacological manipulation of the electron transport chain (ETC) is used to derive parameters such 48 
as the maximal respiration, Spare Respiratory Capacity, ATP-linked turnover and non-mitochondrial 49 
respiration. Such detailed bioenergetics information can be coupled with parallel studies of apoptosis 50 
and necrosis to inform the influence of mitochondrial dysfunction on cell death patterns (Armstrong et 51 
al., 2018). 52 
 53 
Materials and Reagents 54 
 55 
1. 70 µm filters (Fisherbrand, catalog number: 22363548) 56 
2. Tissue paper 57 
3. 30G needle 58 
4. 1.5 ml microcentrifuge tube 59 
5. 15 ml falcon tube 60 
6. Pipette tips 61 
7. Male CD1 or C57BL6/J mice, 8-12 week old (Charles River). 62 
8. Collagenase (Worthington Biochemical Corporation, Lakewood, NJ) 63 
9. PI-CassetteTM (Chemometec, Nucleocounter, catalog number: 941-0001) 64 
10. Reagent A100, Lysis buffer (SKU: 910-0003, Chemometec, Nucleocounter) 65 
11. Reagent B; Stabilizing buffer (SKU: 910-0002, Chemometec, Denmark) 66 
12. XF24 Fluxpak, containing cell plates, cartridge consisting of sensor and utility plates and 67 
Seahorse XF calibrant (Agilent, Seahorse, catalog number: 100850-100) 68 
13. Matrigel basement membrane matrix (Corning, catalog number: 354234) 69 
14. Dimethyl sulfoxide (DMSO, Sigma, catalog number: D2650) 70 
15. Ethyl alcohol, Pure (Sigma, catalog number: 459836) 71 
16. Oligomycin A (Sigma, Merck, catalog number: 75351) 72 
17. Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP, C2920, Sigma, Merck) 73 
18. Antimycin A from Streptomyces sp. (Sigma, Merck, catalog number: A8674) 74 
19. Rotenone (Sigma, Merck, catalog number: R8875) 75 
20. DMEM (Sigma, Merck, catalog number: D5030) 76 
21. L-Glutamine 100x (Gibco, Life Technologies, catalog number: 25030-081) 77 
22. D-Glucose (Sigma, Merck, catalog number: G7528) 78 
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23. Sodium pyruvate (Sigma, Merck, catalog number: P8574) 79 
24. Sodium chloride (Sigma, Merck, catalog number: S9888)  80 
25. Potassium chloride (Sigma, Merck, catalog number: P3911) 81 
26. Magnesium chloride (Sigma, Merck, catalog number: M1028)  82 
27. Calcium chloride (Sigma, Merck, catalog number: 21115) 83 
28. Extracellular solution (see Recipes) 84 
29. Seahorse media (see Recipes) 85 
 86 
Equipment 87 
 88 
1. Surgical scissors 89 
2. Water bath 90 
3. -20 °C freezer 91 
4. Seahorse XF24 Extracellular Flux Analyser (Agilent) 92 
5. Cell Counter NucleoCounter® NC-100TM (900-0004, ChemoMetec, Denmark) 93 
6. Inverted light microscope 94 
 95 
Software 96 
 97 
1. Wave (Seahorse, Agilent. https://www.agilent.com)  98 
2. Prism (GraphPad Software Inc., La Jolla, CA. https://www.graphpad.com) 99 
 100 
Procedure 101 
 102 
Day 1 103 
A. Pancreatic acinar cell preparation 104 
1. Terminate young (8-12 week old) adult CD1 or C57BL/6 (wild type) mouse using an approved 105 
Schedule 1 procedure. 106 
2. Place mouse down on right hand side on fresh tissue paper. 107 
3. Using forceps and scissors cut away fur in the side abdominal area. Once removed make a 108 
similar removal of lower skin epidermis to expose the abdominal cavity. 109 
4. Locate the pancreas below the spleen gently with forceps and cut free with a small pair of 110 
surgical scissors.  111 
5. Place the freshly excised pancreas in 7 ml extracellular solution and keep on ice until digestion. 112 
6. Pre-warm 1 ml of collagenase (200 U ml-1) to 37 °C in a water bath. 113 
7. Carefully inject the pre-warmed collagenase using a 30G needle into the pancreas samples 114 
placed in a weighing boat until the pancreas inflates. Draw up any remaining collagenase not 115 
retained within the pancreas from the weighing boat and re-inject into pancreas. 116 
8. Place the inflated pancreas into a 1.5 ml microcentrifuge tube and add any remaining 117 
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collagenase. 118 
9. Place in a 37 °C water bath for 17 min  119 
Note: This time is dependent on the brand and concentration of collagenase used. You may 120 
need to optimize so that you get a optimal amount of cell viability and cell number achieved. 121 
10. After incubation for 17 min remove from water bath and decant contents of the 1.5 ml 122 
microcentrifuge tube into a 15 ml falcon tube labelled ‘Panc’, quickly add 5 ml of extracellular 123 
solution. 124 
11. Using a 1 ml pipette tip, cut at an angle across the tip and the volume set at 700 µl vigorously 125 
pipette the whole pancreas tissue up and down in and out of the pipette tip to allow for tissue 126 
dissociation (trituration). 127 
12. Repeat pipetting up and down until the mixture becomes cloudy with the release of cells. 128 
13. Upon cessation of pipetting quickly remove the cellular solution into a fresh 15 ml tube labelled 129 
‘Cells’, using a squeezy pipette being careful to leave behind any pieces of pancreas tissue. 130 
14. Add 5 ml of extracellular solution to the 15 ml tube ‘Panc’. 131 
15. Using a fresh 1 ml pipette tip, cut at smaller angle than previously across the tip and the volume 132 
set at 700 µl vigorously pipette the whole pancreas tissue in and out of the pipette tip to allow 133 
further tissue dissociation. 134 
16. Upon cessation of pipetting quickly remove the cellular solution into 15 ml tube ‘Cells’, using a 135 
squeezy pipette and being careful to leave behind any pieces of pancreas tissue. 136 
17. Repeat Steps A14-A16 for a third and final time. 137 
18. Discard any tissue remaining in a 15 ml tube labelled ‘Panc’ 138 
19. Centrifuge 15 ml tube labelled ‘Cells’ for 2 min, 130 x g, room temp. 139 
20. Carefully pour off the supernatant leaving behind the loose cell pellet. 140 
21. Resuspend the cell pellet in 1 ml of extracellular solution. 141 
22. Add an additional 9 ml of extracellular solution. 142 
23. Set up a 70 micron filter in a 50 ml tube (labelled and dated) and pre-wet with a small amount 143 
of extracellular fluid. 144 
24. Filter the 10 ml of cell suspension from the 15ml tube ‘Cells’ through the filter into the 50 ml tube. 145 
25. Rinse the filter with plenty of extracellular fluid until the tube is filled to the 40 ml mark. 146 
26. Centrifuge 50 ml tube labelled ‘Cells’ for 2 min, 130 x g, room temp. 147 
27. Carefully pour off the supernatant leaving behind the loose cell pellet. 148 
28. Resuspend the cell pellet in 1 ml of extracellular solution. 149 
29. Add an additional 9 ml of extracellular solution. 150 
30. Place the tube overnight in at 4 °C. 151 
 152 
B. Oxygen consumption and lactate production analysis cell plate preparation and cartridge 153 
rehydration 154 
1. Remove a Seahorse XF 24 well cell plate and remove from packaging 155 
2. Take a pre-aliquotted 250 µl vial of Matrigel from storage in a -80 °C freezer and thaw on ice. 156 
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3. Adapt Corning’s ‘Thin Coating Method’ for use on a Seahorse XF24 cell plate as follows: 157 
4. Using cooled pipettes, mix the BD Matrigel Basement Membrane Matrix to homogeneity.  158 
5. Dilute Corning Matrigel Basement Membrane Matrix using serum-free medium Seahorse media.  159 
6. Carefully add 36 µl diluted BD Matrigel Basement Membrane Matrix to Seahorse XF 24 well cell 160 
plate being sure not to create any bubbles. 161 
7. Incubate at room temperature for 30 min. 162 
8. Aspirate unbound material and gently rinse using serum-free Seahorse media.  163 
9. Pipette 100 µl serum-free Seahorse media into each well and leave at 4 °C until ready for use. 164 
10. Remove a Seahorse XF 24 cartridge from packaging.  165 
11. Remove the sensor plate (green upper half of the cartridge) and place lid down on the bench. 166 
12. Pipette 1 ml of XF callibrant into each of the 24 wells of the utility plate and return the sensor 167 
plate so the probes of each well are submerged in XF callibrant. 168 
13. Place in a 37 °C CO2 free incubator overnight until ready for use. 169 
 170 
Day 2 171 
C. Assess pancreatic cell viability 172 
1. The next day the cell suspension is mixed to obtain a homogenous suspension by gently 173 
pipetting up and down using a 1 ml pipette. 174 
2. Pipette a 1 ml cell sample from the cell suspension into a 1.5 ml microcentrifuge tube. 175 
3. Label a PI-CassetteTM ‘NV’ (non-viable).  176 
4. Draw the cell suspension into a PI-CassetteTM by inserting the tip of the cassette into the cell 177 
suspension in the 1.5 ml microcentrifuge tube and pressing the piston. 178 
5. Set aside the ‘NV’ PI-Cassette™ to be analysed. 179 
6. Pipette 100 µl of the 1ml cell sample from the 1.5 ml microcentrifuge tube into a second 1.5 ml 180 
microcentrifuge tube. Return any cell sample remaining to the original cell suspension 50 ml 181 
centrifuge tube ‘Cells’. 182 
7. Add 100 µl volume of Reagent A100 to the microcentrifuge tube with the 100 µl cell sample. 183 
8. Mix by pipetting. 184 
9. Add 100 µl volume of Reagent B to the mixture of cell suspension and Reagent A100.  185 
10. Mix by pipetting. 186 
11. Label a PI-CassetteTM ‘T’ (total) 187 
12. Draw the diluted cell suspension into a PI-CassetteTM by inserting the tip of the cassette into the 188 
cell suspension and pressing the piston. 189 
13. Immediately place the loaded PI-CassetteTM in the NucleoCounter® NC-100TMsample tray, press 190 
RUN. 191 
14. After approximately 45 s the total cell concentration (cells/ml) is presented in the bottom right. 192 
15. The cell count produced will normally be in the order of x 105. Divide by 10 to achieve x 106 for 193 
the following calculations 194 
16. Calculate total cell number and percent viability as follows: 195 
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Cell viability = [‘NV’ / (‘T’ x 3)] x 100 196 
Total viable cell count = [(‘T’ x 3) – ‘NV’] x volume of cell suspension 197 
 198 
Examples of total cell count and percent viability previously achieved when isolating acinar cells 199 
from two separate pancreas (taken from two animals) at the same time and pooled for analysis 200 
are shown in Table 1. 201 
 202 
Table 1. Examples of total cell count and percent viability previously achieved 203 
Total read 
out 
Total cell 
count 
Non-viable 
cell count 
Viability (%) Volume (ml)  Total cell 
count (x10 6) 
0.324 0.972 0.137 85.9 10 8.35 
0.211 0.633 0.091 85.6 10 5.42 
0.462 1.386 0.161 88.4 10 12.25 
0.351 1.053 0.018 98.3 10 10.35 
0.302 0.906 0.165 81.8 10 7.41 
0.326 0.978 0.145 85.2 10 8.33 
0.238 0.714 0.152 78.7 10 5.62 
0.224 0.672 0.101 85.0 10 5.71 
0.372 1.116 0.207 81.5 10 9.09 
0.364 1.092 0.219 79.9 10 8.73 
  
Mean ± S.D 85.0 ± 5.6 
 
8.1 ± 2.2 
 204 
17. Centrifuge 50 ml tube labelled ‘Cells’ for 2 min, 130 x g, room temp.  205 
18. Carefully pour off the supernatant leaving behind the loose cell pellet. 206 
19. Resuspend the cell pellet with 1 ml of extracellular solution. 207 
20. The cell suspension needs to be adjusted to a concentration of 1 x 106/ml. This is achieved by 208 
adjusting the volume to the same value as the total number of cells. (Total viable cell count = 5 209 
x 106, adjust cell volume to 5 ml). Centrifuge 50 ml tube labelled ‘Cells’ for 2 min, 130 x g, room 210 
temp. 211 
21. The cells are now ready to be seeded onto the Matrigel coated Seahorse XF 24 well cell plate 212 
(Figure 1). 213 
22. Remove the XF 24 well cell plate and remove the 100 µl serum-free Seahorse media from each 214 
well. 215 
23. Continuously mixing the cell suspension during seeding by pipetting up and down, transfer 75 216 
µl of cell suspension into each well leaving the following cells blank to give a total of 75,000 217 
murine pancreatic cells per well. 218 
 219 
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 220 
Figure 1. Well allocation for blank well for XF24 cell plate 221 
 222 
24. Place the lid back onto the XF24 cell plate and place in a 37 °C CO2 free incubator for 1 hour 223 
for the cells to adhere. 224 
25. Whilst the cells are adhering the XF24 cartridge can be loaded with the compounds that 225 
comprise a mitochondrial “stress” test. 226 
26. After one hour remove the 75 µl of extracellular solution from the cells. Quickly add 450 µl pre-227 
warmed serum free Seahorse media to every well. Return to a 37 °C CO2 free incubator until 228 
ready for use. 229 
 230 
D. Preparing and loading compounds for the mitochondrial “stress” test 231 
1. There are two types of assays that can be performed: 232 
Standard Assay – only involves the injection of modulators included in the kit. 233 
Modified Assay – includes an additional injection of a test compound prior to oligomycin injection, 234 
and Port A is used for the testing compound. 235 
2. Refer to Table 2 for loading volume and port designation for compounds in different types of 236 
assays. 237 
 238 
Table 2. Loading regime for mitochondrial stress test 239 
Port Standard Assay Modified Assay Port 
Concentration 
Port 
Volume 
A Oligomycin Test compound 10x 50 
B FCCP Oligomycin 10x 55 
C Rotenone & Antimycin A FCCP 10x 62 
D Empty Rotenone & Antimycin A 10x 68 
 240 
3. Make a working concentration of 10x the final required concentration required from stock 241 
solutions stored at -20 °C as follows: 242 
a. Oligomycin stock solution in DMSO 243 
10 µl in 1 ml of Seahorse media 244 
For a 10 x solution of 10 µg/ml for a final concentration of 1 µg/ml. 245 
b. Carbonyl cyanide-4 (trifluoromethoxy) phenylhydrazone (FCCP) stock solution in DMSO 246 
X 
X 
X 
X 
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3 µl in 1 ml of Seahorse media 247 
For a 10 x solution of 3 µM for a final concentration of 0.3 µM. 248 
c. Rotenone stock solution in DMSO and Antimycin A stock solution in ethanol 249 
10 µl of each in 1 ml of Seahorse media 250 
For a 10 x solution of 20 µg/ml for a final concentration of 2 µg/ml. 251 
4. Make a vehicle control solution for any well or port that is not receiving a compound or stress 252 
test with appropriate amounts of DMSO/Ethanol or other vehicle utilized for specific compounds. 253 
5. Remove both the sensor plate and the corresponding utility plate together from the 37 °C CO2 254 
free incubator and remove the lid. 255 
6. Load the corresponding volume of each compound appropriate for the assay type into the 256 
appropriate port on the Sensor plate. 257 
7. Once all the compounds have been added to the ports, the lid can be replaced on to the Sensor 258 
plate and return to a 37 °C CO2 free incubator until ready for use. 259 
 260 
E. Oxygen consumption and lactate production analysis 261 
1. Programme the Seahorse Extracellular Flux instrument as follows: 262 
a. Calibration 263 
b. Equilibration 264 
c. [Mix – 2 min, Wait – 2 min, Measure – 2 min] x 5 to ensure a stable baseline 265 
d. Inject Port A 266 
e. [Mix – 2 min, Wait – 2 min, Measure – 2 min] x 3 for standard assay oligomycin injection 267 
or x 5 typically for modified assay which gives 30 min for any test compound application. 268 
f. Inject Port B 269 
g. [Mix – 2 min, Wait – 2 min, Measure – 2 min] x 3 for standard assay FCCP injection and 270 
also x 3 for modified assay, oligomycin injection 271 
h. Inject Port C 272 
i. [Mix – 2 min, Wait – 2 min, Measure – 2 min] x 2 for standard assay Antimycin A/Rotenone  273 
injection and x 3 for modified assay, FCCP injection 274 
j. Inject Port D (modified assay only) 275 
k. [Mix – 2 min, Wait – 2 min, Measure – 2 min] x 2 for modified assay only, Antimycin 276 
A/Rotenone injection  277 
2. After reviewing the group definitions, plate map layout, click Start Run. 278 
3. After you enter the save location for your result file (following completion of the assay), the tray 279 
door on the XF24 Analyser will open. 280 
Important! Before starting calibration, ensure: 281 
4. The sensor cartridge fits properly on the Utility plate. 282 
5. The lid is removed from the sensor cartridge. 283 
6. Proper orientation (direction) of the sensor cartridge on the Utility plate. 284 
7. Place the sensor cartridge (hydrated and loaded with compounds) and Utility plate onto the tray 285 
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when prompted. 286 
8. Press “Start” to initiate sensor cartridge calibration. 287 
9. Time to complete calibration is approximately 10-20 min (for assays at 37°C). For XF assays 288 
performed at temperatures other 37°C an additional 30 min of pre-calibration time will be added 289 
to ensure accurate data acquisition. 290 
10. Once sensor cartridge calibration is complete, the instrument controller will display the Load 291 
Cell Plate dialogue 292 
11. Click Open Tray to eject the Utility plate and load the Cell Plate on the tray. The sensor cartridge 293 
remains inside the XF Analyser for this step. 294 
Important! Before loading the Cell plate, ensure: 295 
12. The lid is removed the Cell Plate. 296 
13. Proper orientation (direction) of the Cell Plate on the tray. 297 
14. After placing the Cell Plate on the tray, click Load Cell Plate to initiate equilibration. 298 
15. After completing equilibration, the assay will automatically begin acquiring baseline 299 
measurements (as outlined in your instrument protocol). 300 
16. Once the final measurement command in the instrument protocol is completed, Wave Controller 301 
software will display the Unload Sensor Cartridge dialog. 302 
17. Click Eject when ready to eject the sensor cartridge and cell plate. Set aside for later analysis if 303 
necessary (example - cell count normalization). 304 
18. After removing the sensor cartridge and cell plate, the Assay Complete dialogue will appear. 305 
19. Click View Results to immediately open your assay result file. Download both files for the 306 
experiment 307 
20. Excel file 308 
21. Xfd. file 309 
 310 
Data analysis 311 
 312 
1. Open the Xfd file in Wave software. 313 
2. You need to change the file format into a Prism file by selecting ‘save as’ and then choosing 314 
the .pzfx format. 315 
3. The data can now be opened directly in prism. 316 
4. Each experimental condition needs at least 3 wells per plate and for statistics needs at least n 317 
= 6 plates using fresh pancreas isolated from a separate mouse each time. 318 
5. Exclusion criteria:  319 
a. Unstable baseline, usually when the baseline shows a steady rate of decline excessively 320 
low or high baseline <200 or > 800 pMol/min OCR.  321 
b. Lack of response by stress test control wells to stress test compounds. 322 
c. Outlier data points – entire series for a well and/or individual data points 323 
 324 
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Notes 325 
 326 
Important! – Before you start your XF Assay 327 
1. Visually inspect the injection ports for even loading. The liquid should be in the port, make sure 328 
there are no residual drops on the top of the sensor cartridge. 329 
2. View cells under a microscope to: 330 
a. Confirm cell health, morphology, seeding uniformity and purity (no contamination). 331 
b. For adherent cells, ensure cells are adhered with a consistent monolayer and were not 332 
washed away during washing step. 333 
Recipes 334 
 335 
1. Extracellular solution (mM) 336 
140 mM NaCl 337 
4.7 mM KCl 338 
1.13 mM MgCl2 339 
1 mM CaCl2 340 
10 mM D-glucose 341 
10 mM HEPES (adjust to pH 7.25 using NaOH) 342 
2. Seahorse media 343 
a. Prepare DMEM by adding 800 ml dH2O to powdered DMEM. 344 
b. Prepare assay medium by supplementing DMEM medium with 1 mM pyruvate, 2 mM 345 
glutamine, and 10 mM glucose as in the table below (Table 3): 346 
 347 
Table 3. Recipe for serum free non-buffered Seahorse media 348 
Reagent/Part Number Final Concentration Volume 
DMEM Medium - 1.0 L 
D-Glucose (1.0 M solution)  10 mM 1.8 g 
Pyruvate (100 mM solution) 1 mM 10 ml 
L-Glutamine (200 mM solution)  2 mM 10 ml 
 349 
c. Bring XF medium with supplements to pH 7.4 and adjust the final volume to 1 litre, transfer 350 
into a Class 2 microbiological safety cabinet.  351 
d. Filter with a filter pipette into sterile 50 ml aliquot centrifuge tubes. Store in a fridge for up to 352 
1 month. 353 
 354 
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